Ukraine proposes $100 bln US weapons deal for security guarantees - FT
Exponent (NASDAQ:EXPO) President and CEO Catherine Corrigan sold a total of 4,896 shares of common stock on August 14, 2025. The sales were executed at a price of $70.9347 for 3,226 shares, and $71.3816 for 1,670 shares, totaling $348,042. The transaction occurred with the stock trading near its current price of $69.25, significantly below its 52-week high of $115.75. According to InvestingPro analysis, the company currently trades at a premium valuation with a P/E ratio of 34.5x.
On the same day, Corrigan also exercised options to acquire a total of 5,606 shares of Exponent common stock. These transactions involved the exercise of stock options at prices of $25.405 and $29.05, resulting in a total value of $151,095. The $3.5 billion market cap company maintains strong financial health, with a current ratio of 3.15 indicating robust liquidity.
Following these transactions, Corrigan directly owns 82,052 shares of Exponent. InvestingPro subscribers can access 10+ additional insights about EXPO’s valuation, financial health, and growth prospects through the comprehensive Pro Research Report, available exclusively with a subscription.
In other recent news, Exponent Inc. reported its second-quarter 2025 earnings, showing a slight increase in revenue. The company posted earnings per share (EPS) of $0.52, surpassing the forecast of $0.4918. Despite exceeding earnings expectations, the stock experienced a decline in aftermarket trading, attributed to concerns over declining billable hours and employee utilization rates. These developments have caught the attention of investors and analysts alike. No analyst upgrades or downgrades were reported in conjunction with these earnings results. However, the financial community remains attentive to Exponent’s performance metrics. As the company navigates these challenges, stakeholders are closely monitoring its operational strategies.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.